Literature DB >> 11156816

Decreased regional brain metabolism after ect.

M S Nobler1, M A Oquendo, L S Kegeles, K M Malone, C C Campbell, H A Sackeim, J J Mann.   

Abstract

OBJECTIVE: The antidepressant action of ECT may be related to its anticonvulsant properties. Positron emission tomography (PET) studies of regional cerebral metabolic rate for glucose were used to test this hypothesis.
METHOD: Ten patients with major depression were studied with PET before and approximately 5 days after a course of bilateral ECT. Statistical parametric mapping was used to identify regions of decreased cerebral glucose metabolism.
RESULTS: Widespread regions of decreased regional cerebral glucose metabolism were identified after ECT, especially in the frontal and parietal cortex, anterior and posterior cingulate gyrus, and left temporal cortex. A region-of-interest analysis similarly indicated post-ECT reductions in regional cerebral glucose metabolism.
CONCLUSIONS: ECT reduces neuronal activity in selected cortical regions, a potential anticonvulsant and antidepressant effect.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11156816     DOI: 10.1176/appi.ajp.158.2.305

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  81 in total

Review 1.  Effects of medications on cerebral blood flow in late-life depression.

Authors:  Mitchell S Nobler; Kristian R Olvet; Harold A Sackeim
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

Review 2.  [Value of diagnostic imaging in evaluation of electroconvulsive therapy].

Authors:  T Frodl; E M Meisenzahl; H-J Möller
Journal:  Nervenarzt       Date:  2004-03       Impact factor: 1.214

Review 3.  Somatic treatments for mood disorders.

Authors:  Moacyr A Rosa; Sarah H Lisanby
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

Review 4.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

5.  A Review of Brain Stimulation Treatments for Late-Life Depression.

Authors:  Daniel M Blumberger; Jonathan H Hsu; Zafiris J Daskalakis
Journal:  Curr Treat Options Psychiatry       Date:  2015-09-28

6.  Long lasting effects of electroconvulsive seizures on brain oxidative parameters.

Authors:  Gustavo Feier; Luciano K Jornada; Tatiana Barichello; Angeles M Vitali; Fernanda Bonatto; José Cláudio F Moreira; Felipe Dal-Pizzol; João Quevedo
Journal:  Neurochem Res       Date:  2006-05-23       Impact factor: 3.996

7.  Pretreatment brain states identify likely nonresponse to standard treatments for depression.

Authors:  Callie L McGrath; Mary E Kelley; Boadie W Dunlop; Paul E Holtzheimer; W Edward Craighead; Helen S Mayberg
Journal:  Biol Psychiatry       Date:  2013-12-19       Impact factor: 13.382

8.  Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder.

Authors:  Jakub Z Konarski; Sidney H Kennedy; Zindel V Segal; Mark A Lau; Peter J Bieling; Roger S McIntyre; Helen S Mayberg
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

9.  Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.

Authors:  Matthew S Milak; Ramin V Parsey; Leilani Lee; Maria A Oquendo; Doreen M Olvet; Francoise Eipper; Kevin Malone; J John Mann
Journal:  Psychiatry Res       Date:  2009-05-14       Impact factor: 3.222

10.  A functional MRI marker may predict the outcome of electroconvulsive therapy in severe and treatment-resistant depression.

Authors:  J A van Waarde; H S Scholte; L J B van Oudheusden; B Verwey; D Denys; G A van Wingen
Journal:  Mol Psychiatry       Date:  2014-08-05       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.